# A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)

> **NCT06749457** · PHASE1,PHASE2 · RECRUITING · sponsor: **AstraZeneca** · enrollment: 231 (estimated)

## Conditions studied

- Staphylococcus Aureus

## Interventions

- **DRUG:** AZD7760
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06749457
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-30
- **Primary completion:** 2026-11-30
- **Final completion:** 2027-09-09
- **Target enrollment:** 231 (ESTIMATED)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06749457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06749457, "A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06749457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*